EP1549291A4 - Injection formulation - Google Patents
Injection formulationInfo
- Publication number
- EP1549291A4 EP1549291A4 EP03725918A EP03725918A EP1549291A4 EP 1549291 A4 EP1549291 A4 EP 1549291A4 EP 03725918 A EP03725918 A EP 03725918A EP 03725918 A EP03725918 A EP 03725918A EP 1549291 A4 EP1549291 A4 EP 1549291A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- injection formulation
- formulation
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ51899702A NZ518997A (en) | 2002-05-16 | 2002-05-16 | Injection formulation for parenteral administration of biodegradable implant for sustained release of active agent |
NZ51899702 | 2002-05-16 | ||
PCT/NZ2003/000095 WO2003097009A1 (en) | 2002-05-16 | 2003-05-16 | Injection formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1549291A1 EP1549291A1 (en) | 2005-07-06 |
EP1549291A4 true EP1549291A4 (en) | 2008-08-20 |
Family
ID=29546531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03725918A Withdrawn EP1549291A4 (en) | 2002-05-16 | 2003-05-16 | Injection formulation |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1549291A4 (en) |
JP (1) | JP2005538052A (en) |
AU (1) | AU2003228174A1 (en) |
CA (1) | CA2486133A1 (en) |
NZ (1) | NZ518997A (en) |
WO (1) | WO2003097009A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060258698A1 (en) | 2005-02-09 | 2006-11-16 | Sreenivasu Mudumba | Liquid formulations for treatment of diseases or conditions |
US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
TWI480908B (en) * | 2009-06-02 | 2015-04-11 | Kurita Water Ind Ltd | Metal electrolytic capacitors and metal electrolytic capacitors with absorbent materials and leak-proof materials |
JP5636637B2 (en) * | 2009-06-02 | 2014-12-10 | 栗田工業株式会社 | Metal electrolytic capacitor |
JP5636640B2 (en) * | 2009-06-23 | 2014-12-10 | 栗田工業株式会社 | Absorbent for metal electrolytic capacitors |
JP5382327B2 (en) * | 2009-06-02 | 2014-01-08 | 栗田工業株式会社 | Metal electrolytic capacitor |
JP5382328B2 (en) * | 2009-06-23 | 2014-01-08 | 栗田工業株式会社 | Leakage prevention material for metal electrolytic capacitors |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5902799A (en) * | 1989-04-23 | 1999-05-11 | The Trustees Of The University Of Pennsylvania | Methods of modulating tissue growth and regeneration |
WO2000071079A2 (en) * | 1999-05-21 | 2000-11-30 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0000730D0 (en) * | 2000-03-06 | 2000-03-06 | Scotia Holdings Plc | Lipid carrier |
EP2283880A3 (en) * | 2000-03-20 | 2014-07-09 | Biosphere Medical, Inc. | Injectable microspheres for tissue construction |
US6436424B1 (en) * | 2000-03-20 | 2002-08-20 | Biosphere Medical, Inc. | Injectable and swellable microspheres for dermal augmentation |
-
2002
- 2002-05-16 NZ NZ51899702A patent/NZ518997A/en not_active IP Right Cessation
-
2003
- 2003-05-16 JP JP2004505008A patent/JP2005538052A/en active Pending
- 2003-05-16 WO PCT/NZ2003/000095 patent/WO2003097009A1/en active Application Filing
- 2003-05-16 EP EP03725918A patent/EP1549291A4/en not_active Withdrawn
- 2003-05-16 CA CA002486133A patent/CA2486133A1/en not_active Abandoned
- 2003-05-16 AU AU2003228174A patent/AU2003228174A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5902799A (en) * | 1989-04-23 | 1999-05-11 | The Trustees Of The University Of Pennsylvania | Methods of modulating tissue growth and regeneration |
WO2000071079A2 (en) * | 1999-05-21 | 2000-11-30 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
Non-Patent Citations (1)
Title |
---|
See also references of WO03097009A1 * |
Also Published As
Publication number | Publication date |
---|---|
NZ518997A (en) | 2004-12-24 |
JP2005538052A (en) | 2005-12-15 |
AU2003228174A1 (en) | 2003-12-02 |
EP1549291A1 (en) | 2005-07-06 |
WO2003097009A1 (en) | 2003-11-27 |
CA2486133A1 (en) | 2003-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2397767B (en) | Injection device | |
GB0229384D0 (en) | Injection device | |
GB0210123D0 (en) | Injection device | |
AU2003256508A8 (en) | Activation-based injection device | |
GB0211294D0 (en) | Improvements relating to injection devices | |
EP1589901A4 (en) | Intracutaneous injection | |
IL172597A0 (en) | Injection device | |
GB0205066D0 (en) | Improvements relating to injection devices | |
GB0319874D0 (en) | Novel formulation | |
GB0207438D0 (en) | Formulation | |
AU2003259457A8 (en) | Auto-destructible syringe | |
GB0205504D0 (en) | Formulation | |
GB0318448D0 (en) | Formulation | |
GB0312195D0 (en) | Formulation | |
EP1549291A4 (en) | Injection formulation | |
GB0320522D0 (en) | Formulation | |
GB0217285D0 (en) | Syringes | |
GB0303876D0 (en) | Formulation | |
EP1507542A4 (en) | Anti-cancer formulation | |
GB0214147D0 (en) | Formulations | |
GB0305560D0 (en) | Fuel formulations | |
EP1693113A4 (en) | Injection disperser | |
GB0213005D0 (en) | Injection nozzle | |
GB0225040D0 (en) | Formulation | |
GB0215589D0 (en) | Formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20041207 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20080717 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20081016 |